Seth Klarman Bristol Myers Squibb CO Transaction History

Baupost Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $186 Million - $270 Million	-4,000,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $295 Million - $385 Million	-6,000,000 Reduced 60.0%	4,000,000 $257 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $128 Million - $152 Million	-3,000,000 Reduced 23.08%	10,000,000 $507 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $402 Million - $444 Million	9,000,000 Added 225.0%	13,000,000 $590 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $180 Million - $215 Million	4,000,000 New	4,000,000 $191 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.